OKYO Pharma Limited (OKYO)
NASDAQ: OKYO · Real-Time Price · USD
1.330
-0.030 (-2.21%)
At close: Sep 21, 2026, 4:00 PM EDT
1.340
+0.010 (0.75%)
After-hours: Sep 21, 2026, 7:30 PM EDT
OKYO Pharma Employees
OKYO Pharma had 5 employees as of March 31, 2026. The number of employees increased by 1 or 25.00% compared to the previous year.
Employees
5
Change (1Y)
1
Growth (1Y)
25.00%
Revenue / Employee
n/a
Profits / Employee
-$1,789,931
Market Cap
69.80M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 5 | 1 | 25.00% |
| Mar 31, 2025 | 4 | 1 | 33.33% |
| Mar 31, 2024 | 3 | -5 | -62.50% |
| Mar 31, 2023 | 8 | 1 | 14.29% |
| Mar 31, 2022 | 7 | 1 | 16.67% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Champions Oncology | 214 |
| Alps Group | 93 |
| XBiotech | 87 |
| Verrica Pharmaceuticals | 76 |
| Pliant Therapeutics | 49 |
| RenovoRx | 17 |
| Cingulate | 14 |
| Alterity Therapeutics | 11 |
OKYO News
- 12 days ago - OKYO Pharma to Present at Ophthalmology Futures European Forum and iNovation Day at ESCRS 2026 - GlobeNewsWire
- 13 days ago - OKYO Pharma to Participate in a Fireside Chat at the Cantor Global Healthcare Conference - GlobeNewsWire
- 4 weeks ago - Okyo Pharma management to meet virtually with Piper Sandler - TheFly
- 7 weeks ago - Okyo Pharma CSO Raj Patil purchases 3,363 shares at $1.49 - TheFly
- 7 weeks ago - OKYO Pharma Announces Purchase of Shares by Chief Scientific Officer - GlobeNewsWire
- 1 month ago - OKYO Pharma to Participate in the BTIG Biotechnology Conference 2026 - GlobeNewsWire
- 2 months ago - Okyo Pharma director John Brancaccio acquires 5,000 shares at $1.38 - TheFly
- 2 months ago - OKYO Pharma Announces Purchase of Shares by Director - GlobeNewsWire